Tackling the global burden of lung disease through prevention and early diagnosis
Three of the top six causes of death worldwide are lung diseases: chronic obstructive pulmonary disease (COPD), lower respiratory tract infections, and lung cancer.
As well as killing 7·6 million people every year, lung disease also causes distressing symptoms and disability for many more. The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
Puedes leer el artículo completo aquí:https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00302-2/fulltext
Noticias relacionadas

“GOLD E” VERSUS “FREQUENT EXACERBATOR” CLASSIFICATIONS IN COPD: A PROTEO-METABOLOMIC PERSPECTIVE [COMUNICACIÓN PREMIADA]
Comparison of COPD exacerbator classification systems (GOLD E vs Frequent Exacerbator) using proteomics and metabolomics to identify biological differences and biomarkers.

The ROME COPD exacerbation proposal works! Time to move forward
The ROME proposal for COPD exacerbations classification offers a new approach to assess severity and predict outcomes, improving clinical decision-making

COPD Management in Primary Care: Underutilisation of Nursing Consultations
Analysis of COPD management in primary care highlighting the role and underutilisation of nursing consultations and healthcare utilisation patterns in real-world patients.
Más artículos
Estudios
- 759397·Alberto Sandiumenge et Al.-Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759689·Kilian Vellvé et Alt.- Pulmonary vascular reactivity in growth restricted fetuses using computational modelling and machine learning analysis of fetal Doppler waveforms.
- 769273· Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- 769685·Nuria Olvera et Al.- Lung Tissue Multi-Layer Network Analysis Uncovers the Molecular Heterogeneity of COPD
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida mediante capturas en el documento enlazado en la parte pública del artículo en (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00302-2/fulltext) : https://www.healthdata.org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf